Irlanti - englanti - HPRA (Health Products Regulatory Authority)

ever valinject gmbh - azacitidine - powder for suspension for injection - 25 milligram(s)/millilitre - azacitidine

Singapore - englanti - HSA (Health Sciences Authority)

advagen pte. ltd. - azacitidine - injection, powder, for suspension - azacitidine 100mg/vial

Euroopan unioni - englanti - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidine - leukemia, myeloid, acute - antineoplastic agents - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

seacross pharma (europe) limited - azacitidine - powder for suspension for injection - 25 milligram(s)/millilitre - azacitidine

Israel - englanti - Ministry of Health

bristol, myers squibb (israel) limited, israel - azacitidine - film coated tablets - azacitidine 200 mg - azacitidine - onureg is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (cr) or complete remission with incomplete blood count recovery (cri) following intensive induction chemotherapy and are not able to complete intensive curative therapy

Israel - englanti - Ministry of Health

bristol, myers squibb (israel) limited, israel - azacitidine - film coated tablets - azacitidine 300 mg - azacitidine - onureg is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (cr) or complete remission with incomplete blood count recovery (cri) following intensive induction chemotherapy and are not able to complete intensive curative therapy

Armenia - englanti - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

seacross pharmaceuticals limited - azacitidine - powder for suspension for injection - 100mg

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - azacitidine - powder for suspension for injection - azacitidine

Malta - englanti - Malta Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - powder for suspension for injection - azacitidine 25 mg/ml - antineoplastic agents

Israel - englanti - Ministry of Health

neopharm ltd - azacitidine - lyophilized powder for suspension for sc injection / solution for infusion - azacitidine 100 mg/vial - azacitidine - azacitidine - for the treatment of patients with the following fab myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.